Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000357097-16-000161
Filing Date
2016-06-24
Accepted
2016-06-24 16:12:47
Documents
1
Period of Report
2016-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_146679915474465.html 4  
1 FORM 4 wf-form4_146679915474465.xml 4 4120
  Complete submission text file 0000357097-16-000161.txt   5741
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Issuer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address
Moore Kelvin (Reporting) CIK: 0001471620 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31564 | Film No.: 161731226